A totally abiotic ELISA-like assay, where no elements of biological origin are used, either for molecular recognition or for reporting purposes, is presented here. Using a novel synthetic approach, with immobilized template, surface-imprinted nanoparticles were prepared with a catalytic core capable of promoting a colorimetric reaction; these were used for combined target recognition and reporting. In microplate-competitive format the assay was capable of selectively determining vancomycin concentration from 10 nM to 1 mM, and with minimal modifications to standard assay protocols. Results point towards the future development of a new generation of assays based entirely on stable and potentially more affordable synthetic reagents.
stability/batch variability and the expense of production and use of antibodies and reporter enzymes.
Molecularly Imprinted Nanoparticles (MIN) capable of recognition of a target molecule have been identified as promising alternatives to antibodies in a range of applications [4] [5] [6] . However, the added advantages (mainly storage/thermal stability and low cost) conferred by the use of imprinted materials as antibody replacements might not be effectively exploited if the assay system still requires the presence of a biological reporter enzyme. Accordingly, here we report the integration of catalytically active Fe3O4 with MIN as combined recognition and signaling functionalities in a core-shell nanoparticle format suitable for use in ELISA-like assays. The intrinsic peroxidase mimicking activity of γFe3O4 nanoparticles has been recently identified, [7] making them attractive substitutes for the enzyme in a variety of assays, with stable catalytic activity over a broad range of temperatures, low cost/long shelf life and ease of manufacture.
In order to produce the composite core-shell Fe3O4-MIN, a variation of the solid-phase imprinting protocol [8] was used, Scheme 1. This method was devised taking into consideration its potential for scale-up and automation, both important factors to consider regarding potential practical applications of the technology. That synthesis and purification time < 1 h per batch of particles is also advantageous. Briefly, the protocol consisted of the addition of monomer mixture and UV initiator, containing a dispersion of 3-(trimethoxysilyl)
propyl methacrylate modified γFe3O4 nanoparticles (d ≤ 50 nm), to the solid phase (glass beads) bearing the immobilized target template (vancomycin). After a short period of UV irradiation (2.5 min), nanoparticles were formed, [9] [8] and the solid phase containing the template and the bound MINs then functioned as an affinity support for the fractionation/purification of high-affinity MINs from the remaining polymer/unreacted monomers (see S. I. for full details), by washing with solvent at room temperature. High affinity materials were collected by elution at 60 °C. Subsequent magnetic separation of the high-affinity particles ensured that only those containing the magnetic Fe3O4 core were so modified Fe3O4 nanoparticles ware used on subsequent experiments. The composition of the polymerization mixture was based on a published protocol [8, 10] and included Nisopropylacrylamide, N-tert-butyl acrylamide, acrylic acid and the cross-linker N, N'-methylenebis(acrylamide). The full composition is given in S. I. Target recognition with this type of polymer can be attributed [4] to a combination of multiple weak electrostatic and hydrophobic interactions and is especially suited to the imprinting of large molecules.
The kinetics of the catalytic oxidation of TMB by Fe3O4 nanoparticles were studied by measuring the absorbance of the solution at 650 nm in 300 sec intervals, and compared for both free Fe3O4 and Fe3O4-MIN nanoparticles. Michaelis-Menten kinetics parameters (vmax and Km) were calculated using the Lineweaver-Burk double reciprocal plot (see S. I, Figure   S2 ). The catalytic constant (kcat) was calculated according to Equation (1):
where Also, this is in accordance with Woo [11] who observed small increases in Vmax values for Fe3O4 nanoparticles after surface derivatization/coating with proteins.
Although imprinted polymers have the potential to directly replace natural receptors in assays such as ELISA, the materials produced using classical protocols have generally proved unsuitable for such applications due to a number of factors. Firstly, traditional MIPs are highly "polyclonal" in relation to their binding behavior (i.e. binding sites distributed throughout the polymer bulk and surface which have a wide range of affinities towards the target molecule) and suffer from high levels of non-specific binding. Secondly, the protocols for integration of imprinted polymers with assays are complicated and non-generic, requiring significant modifications to the procedure used for their manufacture or performance of the assay. Aiming to solve some of these problems we have developed the solid-phase imprinting method for synthesis of MINs with pseudo-monoclonal properties. [8] As detailed in Scheme 1, by combining the affinity separation (for removal of low-affinity MINs) and the fact that instead of whole proteins in this type/format of assay, [12] again, to avoid using potentially unstable or expensive biomaterials. To develop the MIN-based assay, vancomycin was initially conjugated onto the well surface of a 96 well micro plate (via amine coupling, polystyrene plate surface derivatized with maleic anhydride). Then, in order to assess if imprinted nanoparticles cold bind preferentially to this surface, as opposed to surfaces without derivatization, particles were loaded onto the wells which were subsequently washed.
Random/irreproducible peroxidase activity values were detected on wells without coupling techniques will be investigated in the future order to improve the amount of nanoparticles which can be bound to the surface, and so increase the amount of catalytic sites, with consequent increases in measured absorbances. The peroxidase activity was determined by addition of standard colorimetric substrate 3,3′,5,5′-tetramethylbenzidine (TMB) for ELISA and hydrogen peroxide. TMB produces a blue color when oxidized by hydroxyl radicals produced in the presence of a catalyst (such as Fe3O4 or peroxidases) and H2O2. [7] By measuring the rate of color development in the reaction system with TMB, H2O2 and Fe3O4-MINs at different concentrations it was found that the quantity of nanoparticles remaining in the wells after incubation and washing (in the absence of free vancomycin) is equivalent to ca.
20 μg mL -1 . The MIN-based assay was then performed in competitive mode. Upon addition of MINs and vancomycin solutions, the extent of nanoparticles bound to the well surface was Submitted to 6 6 found to be dependent on the amount of free vancomycin in solution (by measuring the peroxidase activity) after incubation and washing to remove unbound MINs. A good correlation was observed between the absorbance of the solution and the concentration of vancomycin over the range from 10 nM to 1 mM (Figure 2) . When control Fe3O4-C particles were used, in the absence of free vancomycin, a response of 89 ± 11 mAU was recorded, as compared to 834 ± 47 mAU for the Fe3O4-MINs (both values obtained after 1 hour incubation with 100 µL nanoparticle solution, 50 µg/mL, loaded in each well and following washing).
The absorbance values obtained with Fe3O4-C were not affected by the presence of vancomycin. While vancomycin was selected primarily as a model analyte, the obtained linear range is well within the recommended serum monitoring levels of 7 to 14 µM, [13, 14] demonstrating potential for the development of vancomycin assays based on this methodology.
The assay was found to be specific, with minimal response to other antibiotics, each present at 0.1 µM Figure 1 field/emergency conditions or in locations where a cold-chain for storage and transport is unavailable.
Supporting Information
Supporting Information is available online from the Wiley Online Library or from the author. Figure 1 . AFM images showing topography of the micro plate well surface before (left) and after 1 hour incubation with 100 µL Fe3O4-MINs (50 µg mL -1 ) and washing (3 × 100 µL) with deionized water.
Figure2.
On the left, scheme of the assay in competitive mode, and on the right, calibration curve for vancomycin obtained with core-shell catalytic MIN (main) and (inset) normalized assay response (cross-reactivity) to different antibiotics, all experiments performed under physiological conditions(PBS 1×, pH 7.2). Solutions of Fe3O4-MINs (100 µL, 50 µg mL -1 ) were added to each of the vancomycin modified wells, followed by 50 µL vancomycin solution. After one hour incubation, wells were washed (3 × 100 µL PBS) and colorimetric TMB assay performed, full details in S. I. Error bars represent ± 1 standard deviation and are for experiments performed in triplicate. 
Submitted to Preparation of vancomycin-derivatized glass beads
The protocol for the immobilization of vancomycin on glass beads has already been described elsewhere.
[SI1] Briefly, glass beads were activated by boiling them in 1M NaOH for 10 min and washed with double-distilled water followed by acetone and then dried. 
Size analysis of nanoparticles
Solutions of nanoparticles at 50 μg/mL were sonicated for 5 minutes and then analyzed at 25 °C using a Zetasizer Nano (Nano-S) from Malvern Instruments Ltd (UK). For transmission electron microscope analyses, Fe3O4-MIN samples were stained with osmium tetroxide by adding 50 µL of 2 % solution to 1 mL nanoparticles solution in water. Solutions were held for 4 hours and then vented on a fume hood overnight to remove excess osmium tetroxide.
Caution! Osmium tetroxide is highly poisonous, even at low exposure levels. After staining, particles were placed on a carbon-coated copper grid and dried on air. The microscope used was a Philips CM20 transmission electron microscope.
AFM analysis
The surface of the interior bottom section of a well from the 96 well micro plate was used for AFM analysis. The instrument was a Bruker Dimension 3100, and analysis performed in tapping mode.
Vancomycin conjugation to the micro plate surface
Micro plate wells were washed with PBS (3×100 μL) then vancomycin solution was added (20 μM, 100 μL, pH 8) and allowed to stand overnight at room temperature. Then the solution was poured out and ethanolamine solution (50 mM, 100 μL) in PBS was added as blocking solution and allowed to stand for 1 h. Afterwards wells were washed twice (100 μL) and airdried.
Assay procedure
To the vancomycin-modified micro plate wells containing nanoparticle suspension (100 μl)
and vancomycin solution at various concentrations (50 μl) were incubated for 1 h with constant shaking. Then the solution was poured out, the wells were washed with PBS (3×100 
